新冠疫情的社会生活科学调查（英文）

DPRIETI Discussion Paper Series 21-E-041Socio-Life Scientific Survey on COVID-19HIROTA, ShigeruRIETISETOH, KazuyaKyoto UniversityYODO, MasatoKyoto UniversityYANO, MakotoRIETIThe Research Institute of Economy, Trade and Industryhttps://www.rieti.go.jp/en/1 RIETI Discussion Paper Series 21-E-041 May 2021 Socio-Life Scientific Survey on COVID-19* Shigeru Hirota (Kyoto Sangyo University/RIETI) Kazuya Setoh (Kyoto University) Masato Yodo (Kyoto University) Makoto Yano (RIETI) Abstract In overcoming the COVID-19 crisis, contribution from social science is indispensable as well as medical research. With this consideration, we have initiated a socio-life scientific survey on COVID-19, which is associated with the antibody test for the virus, targeting 3,000 participants of the Nagahama Survey and 1,000 medical workers at the Kyoto University Hospital. The survey is designed to highlight respondents' changes in behavior, the effect of the COVID-19 outbreak on respondents’ values, and the actual spread of COVID-19 among the respondents. Keywords: COVID-19, Behavior change, Antibody test JEL classification: I12 The RIETI Discussion Paper Series aims at widely disseminating research results in the form of professional papers, with the goal of stimulating lively discussion. The views expressed in the papers are solely those of the author(s), and neither represent those of the organization(s) to which the author(s) belong(s) nor the Research Institute of Economy, Trade and Industry. *This study is conducted as a part of the Project “Toward Building Socio-life Science” undertaken at the Research Institute of Economy, Trade and Industry (RIETI). The authors are grateful to Yoko Ibuka (Keio University), Daigo Nakata (RIETI), Masahiko Nakazawa (Ministry of Finance) and Akihiko Noda (Meiji University) for their useful discussion and Haruhiko Ando, Vice Chairman, RIETI, for his constant encouragement and support. 2 1. Introduction Since it was first confirmed in December 2019 by Chinese health authorities,1 COVID-19 has rapidly spread all over the world.2 In March 2020, many European countries were locked down until May or June.3 Similarly, in the U.S., President Trump declared a national emergency.4 In this process, it has been revealed that elderlies and those with underlying illnesses (of what) tend to suffer from more severe illness.5 Since then, the medical research on COVID-19 has rapidly progressed, and various treatments have been developed; the quick recovery of President Trump from COVID-19 infection has been attributed to a new medicine treatment based on dexamethasone, Regeneron’s monoclonal antibody therapy, and remdesivir.6 Despite all these efforts, however, 70.1 million of people have been infected with about 1.59 million dead as of December 12, 2020.7 While medical research is a key to containing the COVID-19 outbreak, social science provides another key. An early